Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 86.56
PBSV's Cash to Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 86.56 )
PBSV' s 10-Year Cash to Debt Range
Min: 16.5   Max: 187.12
Current: 86.56

16.5
187.12
Equity to Asset 0.88
PBSV's Equity to Asset is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 0.88 )
PBSV' s 10-Year Equity to Asset Range
Min: -0.2   Max: 0.89
Current: 0.88

-0.2
0.89
Interest Coverage 867.43
PBSV's Interest Coverage is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 867.43 )
PBSV' s 10-Year Interest Coverage Range
Min: 9.31   Max: 867.43
Current: 867.43

9.31
867.43
F-Score: 5
Z-Score: 11.10
M-Score: -3.00
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 18.37
PBSV's Operating margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 18.37 )
PBSV' s 10-Year Operating margin (%) Range
Min: 5.38   Max: 27.09
Current: 18.37

5.38
27.09
Net-margin (%) 14.84
PBSV's Net-margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 14.84 )
PBSV' s 10-Year Net-margin (%) Range
Min: 3.28   Max: 16.46
Current: 14.84

3.28
16.46
ROE (%) 27.18
PBSV's ROE (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 27.18 )
PBSV' s 10-Year ROE (%) Range
Min: 7.34   Max: 1588.44
Current: 27.18

7.34
1588.44
ROA (%) 23.05
PBSV's ROA (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 23.05 )
PBSV' s 10-Year ROA (%) Range
Min: 5.67   Max: 29.79
Current: 23.05

5.67
29.79
ROC (Joel Greenblatt) (%) 101.20
PBSV's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 101.20 )
PBSV' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 22.63   Max: 456
Current: 101.2

22.63
456
Revenue Growth (%) 40.00
PBSV's Revenue Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 40.00 )
PBSV' s 10-Year Revenue Growth (%) Range
Min: -13.6   Max: 40
Current: 40

-13.6
40
EBITDA Growth (%) 89.00
PBSV's EBITDA Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 89.00 )
PBSV' s 10-Year EBITDA Growth (%) Range
Min: -39.4   Max: 89
Current: 89

-39.4
89
EPS Growth (%) 119.00
PBSV's EPS Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 119.00 )
PBSV' s 10-Year EPS Growth (%) Range
Min: -46.4   Max: 119
Current: 119

-46.4
119
» PBSV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with PBSV



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Pharma-bio Serv Inc

Pharma Bio Serv: The Perks of Being a Small Investor
PBSV enjoys competitive advantages in a very profitable geographic niche. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 8.50
PBSV's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 8.50 )
PBSV' s 10-Year P/E(ttm) Range
Min: 2.28   Max: 26.07
Current: 8.5

2.28
26.07
P/B 1.50
PBSV's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 1.50 )
PBSV' s 10-Year P/B Range
Min: 0.7   Max: 51
Current: 1.5

0.7
51
P/S 1.00
PBSV's P/S is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 1.00 )
PBSV' s 10-Year P/S Range
Min: 0.23   Max: 1.57
Current: 1

0.23
1.57
PFCF 6.90
PBSV's PFCF is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 6.90 )
PBSV' s 10-Year PFCF Range
Min: 2.13   Max: 34
Current: 6.9

2.13
34
EV-to-EBIT 3.74
PBSV's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 3.74 )
PBSV' s 10-Year EV-to-EBIT Range
Min: 0.2   Max: 11.6
Current: 3.74

0.2
11.6
PEG 0.10
PBSV's PEG is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 0.10 )
PBSV' s 10-Year PEG Range
Min: 0.1   Max: 1.07
Current: 0.1

0.1
1.07
Shiller P/E 10.70
PBSV's Shiller P/E is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 10.70 )
PBSV' s 10-Year Shiller P/E Range
Min: 7.5   Max: 19.91
Current: 10.7

7.5
19.91
Current Ratio 8.53
PBSV's Current Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 8.53 )
PBSV' s 10-Year Current Ratio Range
Min: 1.18   Max: 8.81
Current: 8.53

1.18
8.81
Quick Ratio 8.53
PBSV's Quick Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 8.53 )
PBSV' s 10-Year Quick Ratio Range
Min: 1.18   Max: 8.81
Current: 8.53

1.18
8.81

Valuation & Return

vs
industry
vs
history
Price/Net Cash 2.80
PBSV's Price/Net Cash is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 2.80 )
PBSV' s 10-Year Price/Net Cash Range
Min: 3.2   Max: 31
Current: 2.8

3.2
31
Price/Net Current Asset Value 1.80
PBSV's Price/Net Current Asset Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 1.80 )
PBSV' s 10-Year Price/Net Current Asset Value Range
Min: 1.33   Max: 60
Current: 1.8

1.33
60
Price/Tangible Book 1.50
PBSV's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 1.50 )
PBSV' s 10-Year Price/Tangible Book Range
Min: 0.7   Max: 40
Current: 1.5

0.7
40
Price/DCF (Projected) 0.60
PBSV's Price/DCF (Projected) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 0.60 )
PBSV' s 10-Year Price/DCF (Projected) Range
Min: 0.48   Max: 0.97
Current: 0.6

0.48
0.97
Price/Median PS Value 1.20
PBSV's Price/Median PS Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 1.20 )
PBSV' s 10-Year Price/Median PS Value Range
Min: 0.41   Max: 1.91
Current: 1.2

0.41
1.91
Price/Peter Lynch Fair Value 0.40
PBSV's Price/Peter Lynch Fair Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 0.40 )
PBSV' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.18   Max: 0.76
Current: 0.4

0.18
0.76
Price/Graham Number 0.70
PBSV's Price/Graham Number is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 0.70 )
PBSV' s 10-Year Price/Graham Number Range
Min: 0.41   Max: 4.71
Current: 0.7

0.41
4.71
Earnings Yield (Greenblatt) 26.70
PBSV's Earnings Yield (Greenblatt) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 26.70 )
PBSV' s 10-Year Earnings Yield (Greenblatt) Range
Min: 8.6   Max: 551.7
Current: 26.7

8.6
551.7
Forward Rate of Return (Yacktman) 62.79
PBSV's Forward Rate of Return (Yacktman) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PBSV: 62.79 )
PBSV' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -9.7   Max: 64.1
Current: 62.79

-9.7
64.1

Business Description

Industry: »
Compare: » details
Pharma-bio Serv Inc., is a Delaware corporation, organized in 2004 under the name Lawrence Consulting Group, Inc. In February 2006, its corporate name was changed to Pharma-Bio Serv, Inc. The Company is a compliance and technology transfer services consulting firm with a laboratory testing facility with headquarters in Puerto Rico, servicing the Puerto Rico, United States and Europe markets. It provides a range of compliance related consulting services. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It also provides information technology consulting services and technical training/seminars. The Company markets its services to pharmaceutical, chemical, biotechnology and medical devices, and allied products companies in Puerto Rico, the United States and Europe. The Company competes with regional, national, and international firms.
» More Articles for PBSV

Headlines

Articles On GuruFocus.com
Pharma Bio Serv: The Perks of Being a Small Investor Jun 20 2014 

More From Other Websites
PHARMA-BIO SERV, INC. Financials Jun 21 2014
PBSV: Results Remain Soft But Look For Growth in 2015 Jun 17 2014
Pharma-Bio Serv Announces Stock Repurchase Program and Results for the Quarter Ended April 30, 2014 Jun 16 2014
Pharma-Bio Serv, Inc. Receives Presidential Award for Exports Jun 03 2014
PHARMA-BIO SERV, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... May 02 2014
Revenue Slumps But Not Expected To Be Long-Term Trend Mar 26 2014
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2014 Mar 17 2014
PHARMA-BIO SERV, INC. Files SEC form 10-Q, Quarterly Report Mar 17 2014
PHARMA-BIO SERV, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Feb 21 2014
PBSV: Record Revenue & Net Income. Shares Remain Cheap Jan 31 2014
Pharma-Bio Serv Announces Record Total Net Revenues of $33.1 Million and Record Net Income of $4.9... Jan 29 2014
PHARMA-BIO SERV, INC. Files SEC form 10-K, Annual Report Jan 29 2014
PHARMA-BIO SERV, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 13 2014
Pharma-Bio Serv to Present at Sidoti's Eighth Semi-Annual New York Micro-Cap Conference Jan 10 2014
PHARMA-BIO SERV, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Dec 31 2013
PBSV: Initiating Coverage At Outperform Sep 17 2013
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2013 Sep 16 2013
PHARMA-BIO SERV, INC. Files SEC form 10-Q, Quarterly Report Sep 16 2013
Pharma-Bio Serv: 62% Upside Based On Last Earnings Results Alone Aug 18 2013
PHARMA-BIO SERV, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 23 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide